Skip to main content
TipRanks
Go Ultimate75% OFF

Vistin Pharma ASA (0RAM) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Vistin Pharma ASA has a market cap or net worth of NOK 858.07M. The enterprise value is NOK 798.37M.

Market Cap
NOK 858.07M
Enterprise Value
NOK 798.37M

Share Statistics

Vistin Pharma ASA has 44,344,593 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
44,344,593
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Vistin Pharma ASA’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
-832.43K
Employee Count
74
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, Vistin Pharma ASA had revenue of ― and earned -61.60M in profits. Earnings per share was ―.

Revenue
―
Gross Profit
206.75M
Operating Income
-82.30M
Pretax Income
―
Net Income
-61.60M
EBITDA
27.79M
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
-0.04
52-Week Price Change
-9.09%
50-Day Moving Average
19.01
200-Day Moving Average
20.23
Relative Strength Index (RSI)
25.45
Average Volume (3m)
511

Important Dates

Vistin Pharma ASA upcoming earnings date is Feb 12, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 29, 2026
Next Earnings Date
Feb 12, 2027
Ex-Dividend Date
―

Balance Sheet

Vistin Pharma ASA has ― in cash and marketable securities with NOK 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
NOK 0.00
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for Vistin Pharma ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
-5.20%
EPS Growth Forecast
-19.82%